148 related articles for article (PubMed ID: 33118)
1. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
Shand FL
Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
[TBL] [Abstract][Full Text] [Related]
2. The influence of cyclophosphamide on antibody formation in the mouse.
Willers JM; Sluis E
Ann Immunol (Paris); 1975 Apr; 126(3):267-79. PubMed ID: 1101799
[TBL] [Abstract][Full Text] [Related]
3. Analysis of immunosuppression generated by the graft-versus-host reaction. I. A suppressor T-cell component studied in vivo.
Shand FL
Immunology; 1975 Dec; 29(6):953-65. PubMed ID: 325
[TBL] [Abstract][Full Text] [Related]
4. Analysis of immunosuppression generated by the graft-versus-host reaction. II. Characterization of the suppression cell and its mechanism of action.
Shand FL
Immunology; 1976 Dec; 31(6):943-51. PubMed ID: 11181
[TBL] [Abstract][Full Text] [Related]
5. Activation and suppression of graft-vs-host reactions by cyclophosphamide.
Wander RH; Hilgard HR
J Immunol; 1981 Mar; 126(3):901-4. PubMed ID: 7462635
[TBL] [Abstract][Full Text] [Related]
6. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
7. Kinetics of natural killer cell cytotoxicity during the graft-versus-host reaction. Relationship between natural killer cell activity, T and B cell activity, and development of histopathological alterations.
Ghayur T; Seemayer TA; Lapp WS
Transplantation; 1987 Aug; 44(2):254-60. PubMed ID: 3498241
[TBL] [Abstract][Full Text] [Related]
8. Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.
Huchet R; Bruley-Rosset M; Mathiot C; Grandjon D; Halle-Pannenko O
J Immunol; 1993 Mar; 150(6):2517-24. PubMed ID: 8450227
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppression of normal lymphoid cells by serum from mice undergoing chronic graft-vs-host disease.
McMaster R; Levy JG
J Immunol; 1975 Nov; 115(5):1400-3. PubMed ID: 240891
[TBL] [Abstract][Full Text] [Related]
10. The graft-versus-host reaction and immune function. IV. B cell functional defect associated with a depletion of splenic colony-forming units in marrow of graft-versus-host-reactive mice.
Seddik M; Seemayer TA; Lapp WS
Transplantation; 1986 Feb; 41(2):242-7. PubMed ID: 3511585
[TBL] [Abstract][Full Text] [Related]
11. The origin of cytotoxic T lymphocyte precursors (CTL-P): MHC-restricted and alloreactive CTL-P in the spleen during regeneration after a sublethal dose of cyclophosphamide (Cy).
Sihvola M; Hurme M
J Immunol; 1983 Mar; 130(3):1077-83. PubMed ID: 6600471
[TBL] [Abstract][Full Text] [Related]
12. Participation of cyclophosphamide-sensitive T cells in graft-vs-host reactions.
Schwartz A; Orbach-Arbouys S; Gershon RK
J Immunol; 1976 Sep; 117(3):871-5. PubMed ID: 8571
[TBL] [Abstract][Full Text] [Related]
13. Effect of the treatment of parental cells in vitro with anti-T antibody on bone marrow transplantation in F1 hybrid mice.
Hrubá A; Paluska E; Fricová V; Fiala J
Folia Biol (Praha); 1980; 26(5):338-50. PubMed ID: 7002637
[TBL] [Abstract][Full Text] [Related]
14. Immune dysfunction associated with graft-vs-host reaction in mice transplanted across minor histocompatibility barriers. II. Reversible defect in T-dependent antibody responses.
Budhecha S; Hamilton BL
J Immunol; 1989 Jun; 142(11):3740-5. PubMed ID: 2523932
[TBL] [Abstract][Full Text] [Related]
15. Transfer of immunity by transfer of bone marrow cells: a requirement for T lymphocytes and sensitivity to cyclophosphamide.
Marusić M
Exp Hematol; 1978 Oct; 6(9):725-37. PubMed ID: 361429
[TBL] [Abstract][Full Text] [Related]
16. Subpopulations of mouse T lymphocytes. II. Suppression of graft-vs.-host reactions by naturally proliferating splenic T cells.
Moorhead JW
Eur J Immunol; 1978 Mar; 8(3):163-7. PubMed ID: 26575
[TBL] [Abstract][Full Text] [Related]
17. Amplification of the graft-versus-host reaction by cyclophosphamide: dependence on timing of drug administration.
Lehnert S; Rybka WB
Bone Marrow Transplant; 1994 Apr; 13(4):473-7. PubMed ID: 8019473
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of regulatory T cell circuits by immunoglobulin-dependent structures on activated B cells.
L'age-Stehr J; Teichmann H; Gershon RK; Cantor H
Eur J Immunol; 1980 Jan; 10(1):21-6. PubMed ID: 6965912
[TBL] [Abstract][Full Text] [Related]
19. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
Weiss L; Reich S; Slavin S
Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
[TBL] [Abstract][Full Text] [Related]
20. Suppression of antibody responses in allogeneic mice by products of lymphoid tissue. I. Allogeneic suppressive factor (ASF) from spleens repopulated with thymus cells.
Yonkosky D; Buffett RF; Bennett M
J Immunol; 1976 Jun; 116(6):1688-94. PubMed ID: 58046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
